Status:
COMPLETED
A Phase II Study of KCT-0809 in Patients With Dry Eye Syndrome
Lead Sponsor:
Kissei Pharmaceutical Co., Ltd.
Conditions:
Dry Eye Syndromes
Eligibility:
All Genders
20+ years
Phase:
PHASE2
Brief Summary
To evaluate the efficacy and safety of KCT-0809 compared to placebo in patients with dry eye syndrome.
Eligibility Criteria
Inclusion
- Corneal and conjunctival damage
- Insufficiency of lacrimal secretion
- Ocular symptom
Exclusion
- Severe ophthalmic disorder
- Punctual plugs or surgery for occlusion of the lacrimal puncta
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT01427816
Last Update
October 30 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Japan
Tokyo and Other Japanese City, Japan